SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form PRE 14A - Other preliminary proxy statements:
SEC Accession No. 0000950170-24-035466
Filing Date
2024-03-22
Accepted
2024-03-22 17:05:34
Documents
5
Period of Report
2024-05-16

Document Format Files

Seq Description Document Type Size
1 PRE 14A crbp_pre14a_2024_03_22.htm PRE 14A 1154643
2 GRAPHIC img89200863_0.jpg GRAPHIC 27175
3 GRAPHIC img89200863_1.jpg GRAPHIC 23317
4 GRAPHIC img89200863_2.jpg GRAPHIC 47912
5 GRAPHIC img89200863_3.jpg GRAPHIC 55614
  Complete submission text file 0000950170-24-035466.txt   1368431
Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Filer) CIK: 0001595097 (see all company filings)

IRS No.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
Type: PRE 14A | Act: 34 | File No.: 001-37348 | Film No.: 24776108
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)